Biomira, Inc.

Robert L. Kirkman, M.D. has been named president and chief executive officer of Biomira and was also elected to the board of directors. The company has named Christopher Henney, Ph.D. chairman of the board.

Dr. Kirkman was formerly acting president and chief executive officer of Xcyte Therapies, Inc of Seattle, WA, which concluded a merger with Cyclacel Pharmaceuticals, Inc., in March 2006. From 2004-2005, Dr. Kirkman was chief business officer and vice president at Xcyte and from 1998 to 2003 he was vice president, business development and corporate communications at Protein Design Labs.

Dr. Henney joined the board of directors in March 2005 and is the co-founder of three major publicly traded U.S. biotech companies, Immunex, ICOS and Dendreon. Dr. Henney was chairman and chief executive officer of Dendreon from 1995 to 2004. He is chairman of SGX Pharmaceuticals and vice-chairman of Cyclacel Pharmaceuticals. Mr. Eric Baker, the outgoing chairman of the board, will remain on the board.

The company has also reappointed Robert Blair to the board of directors. “We are glad that Bob Blair has agreed to give us the benefit of his long experience as a prior member of Biomira’s Board,” said Dr. Henney.